Growth/NN
regulation/NN
and/CC
cellular/JJ
changes/NNS
during/IN
differentiation/NN
of/IN
human/JJ
prostatic/JJ
cancer/NN
LNCaP/NN
cells/NNS
as/IN
induced/VBN
by/IN
T/NN
lymphocyte/JJ
-conditioned/JJ
medium/NN
./.

Human/JJ
prostatic/JJ
epithelial/JJ
cells/NNS
from/IN
an/DT
androgen-dependent/JJ
LNCaP/NN
cell/NN
line/NN
were/VBD
examined/VBN
in/IN
response/NN
to/TO
conditioned/JJ
medium/NN
(/(
CM/NN
)/)
derived/VBN
from/IN
phytohemagglutinin/NN
(/(
PHA/NN
)/)
-stimulated/JJ
lymphocytes/NNS
./.
=====
Addition/NN
of/IN
CM/NN
caused/VBD
a/DT
greater/JJR
than/IN
70/CD
%/NN
reduction/NN
of/IN
cell/NN
proliferation/NN
by/IN
cell/NN
counting/NN
and/CC
cell/NN
cycle/NN
./.
=====
These/DT
cells/NNS
showed/VBD
G1/NN
phase/NN
arrest/NN
and/CC
the/DT
clonogenicity/NN
was/VBD
reduced/VBN
./.
=====
The/DT
growth-modulating/JJ
effect/NN
was/VBD
dose-dependent/JJ
and/CC
not/RB
due/JJ
to/TO
cell/NN
lysis/NN
or/CC
apoptosis/NN
./.
=====
The/DT
binding/NN
of/IN
androgen/NN
to/TO
androgen/NN
receptor/NN
on/IN
these/DT
cells/NNS
showed/VBD
approximately/RB
50/CD
%/NN
reduction/NN
,/,
underlining/VBG
a/DT
proliferation/NN
reduction/NN
mechanism/NN
./.
=====
The/DT
prostate-specific/JJ
antigen/NN
(/(
PSA/NN
)/)
was/VBD
downregulated/VBN
to/TO
approximately/RB
75/CD
%/NN
during/IN
the/DT
process/NN
./.
=====
Cell/NN
morphology/NN
showed/VBD
dendritic/JJ
processes/NNS
extending/VBG
from/IN
cytoplasm/NN
and/CC
other/JJ
neuroendocrine/JJ
cell/NN
characteristics/NNS
./.
=====
The/DT
expression/NN
of/IN
several/JJ
cytoskeleton/NN
and/CC
intracellular/JJ
proteins/NNS
increased/VBD
as/IN
determined/VBN
by/IN
immunostaining/NN
on/IN
slides/NNS
and/CC
by/IN
ELISA/NN
procedures/NNS
./.
=====
These/DT
included/VBD
vimentin/NN
,/,
correlating/VBG
to/TO
cell/NN
shape/NN
changes/NNS
,/,
cytokeratins/NNS
8/CD
and/CC
18/CD
,/,
associated/VBN
with/IN
differentiated/VBN
cell/NN
types/NNS
of/IN
prostate/NN
epithelia/NN
,/,
and/CC
neuron-specific/JJ
enolase/NN
and/CC
serotonin/NN
,/,
associated/VBN
with/IN
neuroendocrine/JJ
cells/NNS
./.
=====
From/IN
these/DT
cellular/JJ
changes/NNS
,/,
we/PRP
can/MD
infer/VB
that/IN
the/DT
cell/NN
growth/NN
was/VBD
modulated/VBN
along/IN
with/IN
induction/NN
of/IN
terminal/JJ
differentiation/NN
./.
=====
Activated/VBN
T/NN
cells/NNS
were/VBD
demonstrated/VBN
to/TO
be/VB
important/JJ
in/IN
providing/VBG
the/DT
modulating/NN
activity/NN
./.
=====
This/DT
growth/NN
modulator/NN
was/VBD
semipurified/VBN
and/CC
had/VBD
an/DT
estimated/VBN
molecular/JJ
weight/NN
13,000/CD
to/TO
24,000/CD
Da/NN
./.
=====
The/DT
activity/NN
was/VBD
determined/VBN
to/TO
be/VB
distinct/JJ
from/IN
TGF/NN
,/,
TNF/NN
,/,
and/CC
some/DT
commonly/RB
known/JJ
lymphokines/NNS
./.
=====
The/DT
interaction/NN
between/IN
lymphoid/JJ
and/CC
prostatic/JJ
cells/NNS
in/IN
growth/NN
and/CC
development/NN
is/VBZ
described/VBN
./.